Antigenic meningococcal peptides
CA 2801979 A1 · Owner: Novartis Vaccines And Diagnostics Srl · Inventors: Mora, Mariarosa; Scarselli, Maria; Masignani, Vega
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
WO99/36544 discloses a large number of proteins from Neisseria Meningitidis. The present invention relates to fragments of those proteins which comprise at least one antigenic determinant. Homologous sequences and proteins comprising these fragments are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 13, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 13, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 13, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.